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breaks or apurinic sites in HeLa cell DNA by
methylmethane sulphonate have been ob-
tained, knowing the extent of methylation of
DNA by the compound (Roberts et al.,
Chem. Biol. Interact., 1971, 3, 29). High
doses of MAM acetate (1 hour treatment)
had no effect on the sedimentation rate of
template DNA, and this is taken as evidence
that, compared with MMS, MAM acetate is
toxic at low levels of DNA methylation in
HeLa cells. However, ligation of DNA
synthesized after MAM acetate treatment is
inhibited.
In cells exposed to physiological doses of
the carcinogen, ligation of DNA synthesized
immediately after treatment appears to be
completed, but 24 hours after treatment,
when these cells have divided and DNA
synthesis is inhibited (Van den Berg and
Ball, Mttation Res., 1972, 16, 381), the
assembly of newly synthesized DNA is
severely affected.
The results may be of significance in
relation to the suggestion that 0-6 methyl-
guanine may be an important toxic lesion in
HeLa cells exposed to carcinogenic methyl-
ating agents.
THE KINETIC RESPONSE OF HeLa
CELLS TO MAM ACETATE TREAT-
MENT, A. J. Bedford, J. C. Knowles, T. E.
Kenny and H. W. Van den Berg, Department
of Cancer Research, University of Leeds.
Kinetic analyses of synchronized HeLa
cells treated in G1 with the carcinogenic
methylating agent MAM acetate have been
performed using the techniques of microcine-
matography.
Results obtained showed that the first
cycle after treatment was extended by a
short period (cycle time = 1,400 min com-
pared with control time of 1000 min) but all
cells successfully divided. The major effect
of the drug is expressed in the second cycle,
resulting in an extension of interphase and
mitosis (cycle time = 3600 min). These re-
sults are in agreement with other earlier
biochemical findings (Van den Berg and Ball,
Mutation Res., 1972, 16, 381).
The cell cycle times for survivors of the
third and fourth cycles return to near normal
values consistent with completion of a re-
covery process during the second cycle.
Alow correlation (r = 0.55) existsbetween
the cycle times of surviving daughter pairs in
the third cell cycle, but correlations approach
control values in the other cell cycles
(r = 0.95).
The toxicity ofthe drug is apparent in the
second and third cycles (5000 death/cycle)
and the timing of cell death falls into two
distinct groups: late death, the major type in
the second cycle (mean = 4353 ± 608 min)
and early death, predominant in the third
cycle (mean = 651 ± 216 min). These two
groups may also be distinguished on mor-
phological grounds.
HISTOLOGY OF TUMOUR FORMA-
TION IN THE BLADDER OF RATS
RECEIVING DIETARY SACCHARIN
AND A SINGLE DOSE OF N-METHYL
N-NITROSOUREA, J. Chowaniec, R. M.
Hicks and J. St. J. Wakefield, School of
Pathology, The Middlesex Hospital Medical
School, London.
Preliminary results indicated that dietary
saccharin could act as a co-carcinogen with
N-methyl N-nitrosourea at doses at which
neither alone produces tumours (Hicks,
Chowaniec and Wakefield, Nature, Lond.,
1973, 243, 424). The incidence of further
bladder tumours in animals from this and
other experiments using higher doses of
saccharin confirms this observation. Most
tumours are epithelial and vary from papil-
lary outgrowths and sessile transitional cell
tumours to invasive squamous metaplasia.
Some sarcomata are also observed.
The rise inurinary pH in animals receiving
saccharin predisposes to the formation of
urinary calculi in the bladder, ureters and
kidney. Histological examination indicates
that some calculi originate below the epi-
thelium. This suggests a breakdown of the
normal epithelial permeability barrier, thus
allowing the pH of the tissue fluids in the
bladder wall to rise in parallel with the urine.
TOXIC EFFECT OF N-METHYL-N-
NITROSOUREA ON NORMAL AND
TRANSFORMED CELLS, Ray Wilkinson
and A. H. W. Nias, Courtauld Institute of
Biochemistry, TheMiddlesexHospitalMedical
School and Glasgow Institute of Radiothera-
peutics, Glasgow.
Mammalian cells treated in vitro with
carcinogenic chemicals exhibit characteristics
of neoplasia and associated resistance to the
toxic effects ofthe carcinogen. Investigation94 B.A.C.R. AUTUMN MEETING
of this resistance may illuminate critical sites
of the cell-carcinogen interaction.
Cells treated in vitro with N-methyl-N-
nitrosourea, MNU, exhibited malignant trans-
formation and were ten-fold more resistant
to MNU toxicity than previously treated
normal cells. Transformation and resistance
were related and dose dependent. MNU
resistant cells were twice as resistant to
methyl methanesulphonate toxicity and ten-
fold more resistant to the toxic effect of
thymidine, compared wvith normal cells.
Resistance to MNU and thymidine could
not be explained by reduced incorporation,
as measured by the uptake of the respective
radioactively labelled compound. The cross
resistance suggested similar sites may be
involved in MNU and thymidine toxicity.
(Studies performed at the Paterson Labora-
tories, Christie Hospital, Manchester.)
INHIBITION OF THE EFFECTS OF
METHYLCHOLANTHRENE BY VITA-
MIN A AND VITAMIN A ANALOGUES,
Ilse Lasnitzki and De Witt S. Goodman,
Strangeways Research Laboratory, Cam-
bridge.
Retinol and retinoic acid have been shown
to inhibit carcinogenesis in vitro and in vivo
but their possible clinlical use may be limited
by their high toxicity. Vitamin A analogues
without the biological properties of the
natural vitamin may serve as substitutes.
The influence of two analogues, ox-retinoic
acid and anhydroretinoic acid, on the effect
of methylcholanthrene was examined in
mouse prostates grown in vitro and compared
with that of retinol and retinoic acid.
The carcinogen alone induced extensive
epithelial hyperplasia and dysplasia. All
four compounds, applied at various dose
levels, were highly active in inhibiting this
effect. At the highest concentration they
almost totally suppressed the hyperplasia, at
the lowest concentration retinoic acid and
anhydroretinoic acid were the most effective
inhibitors. Mechanisms involved in the
antagonism have been investigated.
IMMUNOGENICITY OF EMBRYONIC
ANTIGENS ASSOCIATED WITH
CHEMICALLY INDUCED RAT TU-
MOURS, R. W. Baldwin and B. M. Vose,
Cancer Research Laboratories, University of
Nottingham.
Chemically induced rat hepatomata and
sarcomata express neoantigens at the cell
surface which are also detectable on mid-
gestation rat embryo cells. These antigens
are revealed by the cytotoxicity ofserum and
lymph node cells from multiparous female
rats for embryo and tumour cells by serum
from these animals. Since the multiparous
rat becomes sensitized to these antigens, they
are immunogenic when expressed on embryo
cells in the pregnant host. Immunization of
syngeneic rats with mid-gestation rat emblryo
cells failed, however, to elicit immunity to
challenge with hepatomata or sarcomata.
Also, lymphoid cells from multiparous rats
were ineffective for adoptively transferring
tumour immunity. These studies are dis-
cussed in connection with the view that the
tumour specific rejection antigens on these
tumours differ from the tumour associated
embryonic antigens.
"WILD" TYPE ANTIGENS OF SAR-
COMATA INDUCED BY A NATURAL
AMINE SARCOMA VIRUS (MSV-FBJ),
David B. Jones and Michael Moore, Charles
Salt Research Centre, The Robert Jones and
Agnes Hunt Orthopaedic Hospital, Oswestry.
MSV-FBJ is a C-type murine oncorna-
virus which induces primitive mesenchymal
sarcomata of long latency in mice. The
agent was originally isolated from a sponta-
neous murine osteosarcoma and is of demon-
strated " wild " type antigencity.
Transplantation rejection techniques have
demonstrated a tumour associated antigen
common to all cells transformed by MSV-FBJ
and also present on cells infected with " wild "
type Gross leukaemia virus. The specificity
was absent from cells transformed by the
" non-wild " type isolate MSV-Harvey (MSV-
H).
Serum from mice immunized against
MSV-FBJ sarcoma cells reacted in the
indirect membrane immunofluorescence test
with both MSV-FBJ sarcoma cells and Gross
antigen bearing cells, but not with the
membrane of MSV-H cells. Further, aged
C57B1 serum specifically reactivewithcellular
rather than virion specificities of Gross virus
infected cells reacted with MSV-FBJ sarcoma
cells. Identification ofantigens onthe surface
of MSV-FBJ sarcoma cells which were not
also present on " wild " type antigen-bearing
tumours could not be achieved by absorption
techniques.